Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840

Condition:   Wilson Disease Intervention:   Drug: ALXN1840 Sponsor:   Alexion Pharmaceuticals Recruiting

Source: ClinicalTrials.gov - October 2, 2020 Category: Research Source Type: clinical trials